ARF like GTPase 8B (Ensembl:ADP-ribosylation factor like GTPase 8B)
RGD ID:
1562830
Description:
Predicted to enable G protein activity; guanyl ribonucleotide binding activity; and tubulin binding activity. Predicted to be involved in several processes, including antigen processing and presentation following phagocytosis; lysosomal transport; and vesicle fusion. Predicted to act upstream of or within early endosome to Golgi transport and endosomal vesicle fusion. Predicted to be located in several cellular components, including cytolytic granule membrane; midbody; and spindle midzone. Predicted to be active in early endosome membrane and lysosomal membrane. Orthologous to human ARL8B (ARF like GTPase 8B); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; bisphenol A.
ADP-ribosylation factor like GTPase 8B; ADP-ribosylation factor-like 8B; ADP-ribosylation factor-like protein 8B; LOC500282; similar to ADP-ribosylation factor-like 10C
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARL8B more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...